Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Zhu, Feng‐cai
516  Ergebnisse:
Personensuche X
?
1

Construction of immune-related molecular diagnostic and pre..:

Zheng, Hui ; Han, Xu ; Liu, Qian...
Heliyon.  10 (2024)  2 - p. e24854 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Efficacy, reactogenicity, and safety of the adjuvanted reco..:

Alexandra Echeverria Proano, Diana ; Zhu, Fengcai ; Sun, Xiaodong...
Human Vaccines & Immunotherapeutics.  20 (2024)  1 - p. , 2024
Link: https://doi.org/10.1080/..
 
?
3

Active surveillance of hepatitis E: a 10-year epidemiologic..:

Huang, Xingcheng ; Zheng, Xiaoxiang ; Chen, Lin...
Emerging Microbes & Infections.  13 (2024)  1 - p. , 2024
Link: https://doi.org/10.1080/..
 
?
4

The era of SARS-CoV-2 variants calls for an urgent strategy..:

Li, Si-Min ; Zhu, Feng-Cai
The Lancet Infectious Diseases.  24 (2024)  7 - p. 666-667 , 2024
Link: https://doi.org/10.1016/..
 
?
5

Vaccination with Adenovirus Type 5 Vector-Based COVID-19 Va..:

Zhu, Yawen ; Tang, Rong ; Li, Xiaolong...
Vaccines.  12 (2024)  3 - p. 292 , 2024
Link: https://doi.org/10.3390/..
 
?
6

Safety and immunogenicity of the SARS-CoV-2 LYB001 RBD-base..:

Tang, Rong ; Zeng, Ying ; Zhou, Yu...
Expert Review of Vaccines.  23 (2024)  1 - p. 498-509 , 2024
Link: https://doi.org/10.1080/..
 
?
7

Immunogenicity and safety of an ORF7-deficient skin-attenua..:

Pan, Hong-Xing ; Qiu, Ling-Xian ; Liang, Qi...
The Lancet Infectious Diseases.  , 2024
Link: https://doi.org/10.1016/..
 
?
8

Efficacy, safety, and immunogenicity of SARS-CoV-2 mRNA vac..:

Zhou, Huan ; Zheng, Hui ; Peng, Yucai...
Frontiers in Immunology.  15 (2024)  - p. , 2024
Link: https://doi.org/10.3389/..
 
?
9

Nasal Staphylococcus aureus Carriage and Antimicrobial Resi..:

Hu, Wenjing ; Wang, Yang ; Zhou, Lu...
Infectious Diseases and Therapy.  13 (2024)  6 - p. 1215-1233 , 2024
Link: https://doi.org/10.1007/..
 
?
10

Relative effectiveness of a heterologous booster dose with ..:

Jia, Siyue ; Yin, Zundong ; Pan, Hongxing...
Emerging Microbes & Infections.  13 (2024)  1 - p. , 2024
Link: https://doi.org/10.1080/..
 
?
11

Immunogenicity, Safety, and Immune Persistence of One Dose ..:

Han, Xu ; Wei, Mingwei ; Zheng, Xiuyu...
Vaccines.  12 (2024)  6 - p. 683 , 2024
Link: https://doi.org/10.3390/..
 
?
12

Correction to: Safety and Immunogenicity of a Recombinant T..:

Wynne, Chris ; Balgos, Abundio ; Li, Jingxin...
Infectious Diseases and Therapy.  13 (2024)  7 - p. 1723-1724 , 2024
Link: https://doi.org/10.1007/..
 
?
13

Long-term efficacy of a recombinant hepatitis E vaccine in ..:

Huang, Shoujie ; Zhang, Xuefeng ; Su, Yingying...
The Lancet.  403 (2024)  10429 - p. 813-823 , 2024
Link: https://doi.org/10.1016/..
 
?
14

Safety and Immunogenicity of a Recombinant Two-Component SA..:

Wynne, Chris ; Balgos, Abundio ; Li, Jingxin...
Infectious Diseases and Therapy.  13 (2023)  1 - p. 57-78 , 2023
Link: https://doi.org/10.1007/..
 
?
15

Immunogenicity and safety of heterologous immunisation with..:

Jin, Peng-Fei ; Guo, Xi-Ling ; Gou, Jin-Bo...
The Lancet Regional Health - Western Pacific.  38 (2023)  - p. 100829 , 2023
Link: https://doi.org/10.1016/..
 
1-15